Synthetic drug ebselen could be repurposed to treat SARS-CoV-2 by targeting main protease at distant

The synthetic drug ebselen can bind to both the catalytic region and a previously unknown distant site on the SARS-CoV-2 virus’ main protease, according to a molecular simulation analysis of the drug’s interactions with this enzyme.